EP2739744A1 - Oxydation et amination d'alcools secondaires - Google Patents

Oxydation et amination d'alcools secondaires

Info

Publication number
EP2739744A1
EP2739744A1 EP12740366.5A EP12740366A EP2739744A1 EP 2739744 A1 EP2739744 A1 EP 2739744A1 EP 12740366 A EP12740366 A EP 12740366A EP 2739744 A1 EP2739744 A1 EP 2739744A1
Authority
EP
European Patent Office
Prior art keywords
group
transaminase
alcohol
nad
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12740366.5A
Other languages
German (de)
English (en)
Inventor
Thomas Haas
Markus PÖTTER
Jan Christoph Pfeffer
Wolfgang Kroutil
Arne Skerra
Alexandra Lerchner
Katharina Christin TAUBER
Johann H. SATTLER
Steffen Schaffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa GmbH filed Critical Evonik Degussa GmbH
Priority to EP12740366.5A priority Critical patent/EP2739744A1/fr
Publication of EP2739744A1 publication Critical patent/EP2739744A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01001—Alcohol dehydrogenase (1.1.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y206/00—Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01—Transaminases (2.6.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y206/00—Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01—Transaminases (2.6.1)
    • C12Y206/01018—Beta-alanine-pyruvate transaminase (2.6.1.18)

Definitions

  • the present invention relates to a process comprising the steps of a) providing a secondary alcohol b) oxidation of the secondary alcohol by contacting with an NAD (P) + -dependent alcohol dehydrogenase, and c) contacting the oxidation product from step a) with a transaminase, wherein the NAD (P) + -dependent alcohol dehydrogenase and / or the transaminase is a recombinant or isolated enzyme, a whole-cell catalyst for carrying out the process, and the use of such a whole-cell catalyst for the oxidation of a secondary alcohol.
  • Amines are used as synthesis building blocks for a large number of products of the chemical industry, such as epoxy resins, polyurethane foams, isocyanates and, in particular, polyamides.
  • the latter are a class of polymers characterized by repeating amide groups.
  • polyamides unlike the chemically related proteins, usually refers to synthetic, commercially available, thermoplastics.
  • Polyamides are derived from primary amines or secondary amines which are conventionally obtained when cracking hydrocarbons Aminocarboxylic acids, lactams and diamines can be used for the production of polymers, and short-chain, gaseous alkanes as starting materials which can be obtained from renewable raw materials by means of biotechnological processes are also of interest.
  • polyamide 6 can be obtained by polymerizing ⁇ -caprolactam and "polyamide 12" by polymerizing laurolactam.
  • Other commercially interesting products include copolymers of lactam, e.g. B. Copolymers of ⁇ -caprolactam and laurolactam.
  • the conventional chemical-technical production of amines is dependent on the supply of fossil fuels, inefficient, and thereby accumulate large amounts of unwanted by-products, in some steps of the synthesis up to 80%.
  • An example of such a process is the production of laurolactam, which is conventionally obtained by trimerization of butadiene.
  • the trimerization product cyclododecatriene is hydrogenated and the resulting cyclododecane is oxidized to cyclodecanone, which is then reacted with hydroxylamine to cyclododecanoxine, which is finally converted via a Beckmann rearrangement to laurolactam.
  • PCT / EP 2008/067447 describes a biological system for producing chemically related products, more specifically ⁇ -aminocarboxylic acids, using a cell which has a number of suitable enzymatic activities and is capable of converting carboxylic acids to corresponding ⁇ -aminocarboxylic acid.
  • a known disadvantage of the alkBGT oxidase system of Pseudomonas putida GP01 used in this case is that it is not able to afford a selective oxidation of aliphatic alkanes to secondary alcohols.
  • the object underlying the invention is to provide an improved process for the oxidation and amination of secondary alcohols using biocatalysts. Another object is to improve the process so that the yield is increased and / or the concentration of by-products is lowered. Finally, there is a need for a method that the Production of polyamides or educts allowed for their production on the basis of renewable resources.
  • the object is achieved in a first aspect by a process comprising the steps of a) providing a secondary alcohol, b) oxidation of the secondary alcohol by contacting with an NAD (P) + -dependent alcohol dehydrogenase, and c) contacting the oxidation product from step a ) with a transaminase, wherein the NAD (P) + alcohol dehydrogenase and / or the transaminase is a recombinant or isolated enzyme.
  • the secondary alcohol is an alcohol selected from the group comprising ⁇ -hydroxycarboxylic acids, cycloalkanols, preferably bis (p-hydroxycyclohexyl) methane, the alcohols of the formulas R 1 -CR 2 H-CR 3 H OH and their ethers and polyethers, and secondary alkanols, preferably 2-alkanols, where R 1 is selected from the group consisting of hydroxyl, alkoxyl, hydrogen and amine, R 2 is selected from the group consisting of alkyl Methyl, ethyl and propyl, and hydrogen, and R 3 is selected from the group comprising alkyl, preferably methyl, ethyl and propyl
  • the secondary alcohol is a secondary alcohol of the formula
  • R 4 is selected from the group comprising -OH, -SH, -NH 2 and -COOR 5 , x is at least 3, and R 5 is selected from the group comprising H, alkyl and aryl.
  • step a) is carried out by hydroxylation of a corresponding alkane of the formula by a monooxygenase, which is preferably recombinant or isolated.
  • the NAD (P) + -dependent alcohol dehydrogenase is an NAD (P) + -dependent alcohol dehydrogenase having at least one zinc atom as a cofactor.
  • the alcohol dehydrogenase is the alcohol dehydrogenase A of Rhodococcus ruber (database code AJ491307.1) or a variant thereof.
  • the monooxygenase is selected from the group comprising AlkBGT of Pseudomonas putida, Cytochrome P450 of Candida tropicalis or Cicer arietinum.
  • the transaminase is selected from the group of transaminases and their variants which are characterized in that they are at the position of the amino acid sequence, the Val224 from the transaminase of Chromobacterium violaceum ATCC 12472 (database code NP_901695), one amino acid selected from the group comprising isoleucine, valine, phenylalanine, methionine and leucine, and at the position of the amino acid sequence corresponding to Gly230 from the transaminase of Chromobacterium violaceum ATCC 12472 (database code NP_901695), an amino acid other than threonine and preferably an amino acid from the group comprising serine, cysteine, glycine and alanine, or the transaminase is selected from the group comprising the transaminase of Vibrio fluvialis (AEA3918
  • step b) and / or step c) is carried out in the presence of an isolated or recombinant alanine dehydrogenase and an inorganic nitrogen source, preferably ammonia or an ammonium salt.
  • At least one enzyme from the group comprising NAD (P) + -dependent alcohol dehydrogenase, transaminase, monooxygenase and alanine dehydrogenase is recombinant and provided in the form of a whole-cell catalyst, which has the corresponding enzyme.
  • all enzymes are provided in the form of one or more than one whole cell catalyst, preferably a whole cell catalyst having all the required enzymes.
  • an organic cosolvent is present which has a log P of more than -1, 38, preferably -0.5 to 1, 2, more preferably -0.4 to 0.4.
  • the co-solvent is selected from the group comprising unsaturated fatty acids, preferably oleic acid.
  • the cosolvent is a compound of the formula R 6 -O- (CH 2 ) X -O-R 7 wherein R 6 and R 7 and 4 are each independently selected from the group comprising methyl, ethyl, propyl and butyl and x is 1 to 4, preferably R 6 and R 7 are each methyl and x is 2.
  • the object is achieved in a second aspect by a whole-cell catalyst comprising an NAD (P) + -dependent alcohol dehydrogenase, preferably with at least one zinc atom as cofactor, a transaminase, optionally a monooxygenase and optionally an alanine dehydrogenase, wherein the enzymes are recombinant Enzymes, wherein the alcohol dehydrogenase recognizes preferably as a preferred substrate, a secondary alcohol.
  • NAD (P) + -dependent alcohol dehydrogenase preferably with at least one zinc atom as cofactor
  • a transaminase optionally a monooxygenase and optionally an alanine dehydrogenase
  • the enzymes are recombinant Enzymes, wherein the alcohol dehydrogenase recognizes preferably as a preferred substrate, a secondary alcohol.
  • the object in a third aspect is achieved by the use of the whole-cell catalyst according to the second aspect of the present invention for the oxidation and amination of a secondary alcohol, preferably of the formula H 3 C - C (OH) H - (CH 2 ) X - R 1 , wherein R 1 is selected from the group comprising -OH, -SH, -NH 2 and -COOR 2 , x is at least 3 and R 2 is selected from the group comprising H, alkyl and aryl.
  • a secondary alcohol preferably of the formula H 3 C - C (OH) H - (CH 2 ) X - R 1 , wherein R 1 is selected from the group comprising -OH, -SH, -NH 2 and -COOR 2 , x is at least 3 and R 2 is selected from the group comprising H, alkyl and aryl.
  • the use further comprises the presence of an organic cosolvent having a log P of greater than -1, 38, preferably -0.5 to 1, 2, more preferably 0.4 to 0.4, and most preferably dimethoxyethane.
  • the co-solvent is selected from the group comprising unsaturated fatty acids, and is preferably oleic acid.
  • inventions of the second and third aspects include all embodiments of the first aspect of the present invention.
  • the inventors of the present invention have surprisingly found that there is a group of alcohol dehydrogenases that can be used to effect the oxidation of secondary alcohols to produce minor amounts of by-products.
  • the inventors have further surprisingly found that a cascade of enzymatic activities exist whereby alcohols can be aminated without appreciable by-product formation using biocatalysts, with no reduction equivalents to be added or removed.
  • the inventors have also surprisingly found a process by which polyamides can surprisingly be prepared using a whole-cell catalyst and starting from renewable raw materials.
  • the inventors of the present invention have further surprisingly found that the amination of secondary alcohols after prior oxidation can be carried out particularly advantageously with a group of transaminases characterized by particular sequence properties.
  • ⁇ -hydroxycarboxylic acids preferably those which can be oxidized to the ⁇ -ketocarboxylic acids, ie those of the formula R s -C (OH) H-COOH, which in turn can be converted by amination to the proteinogenic amino acids, including in particular essential amino acids such as methionine and lysine.
  • R s is a substituent selected from the group consisting of H, methyl, - (CH 2 ) 4 -NH 2 , - (CH 2 ) 3 -NH-NH-NH 2 , -CH 2 -CH 2 -S-CH 3 , -CH (CH 3 ) 2 , -CH 2 -CH (CH 3 ) 2 , -CH 2 - (1H-indol-3-yl), -CH (OH) -CH 3 , - CH 2 -phenyl, -CH (CH 3 ) -CH 2 -CH 3 .
  • Secondary alcohols include 2-alkanols, for example 2-propanol, 2-butanol, 2-pentanol, 2-hexanol, etc.
  • secondary polyhydric alcohols for example alkanediols such as ethanediol, alkanetriols such as glycerol and pentaerythritol.
  • alkanediols such as ethanediol
  • alkanetriols such as glycerol and pentaerythritol.
  • cycloalkanols preferably cyclohexanol and bis (p-hydroxycyclohexyl) methane, the alcohols of the
  • R 4 is selected from the group comprising -OH, -SH, -NH 2 and -COOR 5 , x is at least 3, and R 5 is selected from the group comprising H, alkyl and aryl.
  • the length of the carbon chain in the case of alcohols of the formula H 3 C - C (OH) H - (CH 2 ) X - R 4 alcohols is variable and x is at least 3.
  • Numerous secondary alcohols are commercially available and can be used directly in commercial form.
  • the secondary alcohol can be biotechnologically generated beforehand or in situ, for example by hydroxylation of an alkane by suitable alkane oxidases, preferably monooxygenases.
  • suitable enzymes for example MW Peters et al., 2003.
  • R 4 is in the case of secondary alcohols of the formula H 3 C - C (OH) H - (CH 2)
  • X - R 4 is selected from the group -OH, and -COOR comprises 5, x is at least 1 1 and R 5 is selected from the group comprising H, methyl, ethyl and propyl.
  • NAD (P) + -dependent alcohol dehydrogenases are used for the oxidation of the secondary alcohol.
  • these may be cells comprising enzymatically active polypeptides or their lysates or preparations of the polypeptides in all purification stages, from the crude lysate to the pure polypeptide.
  • Numerous methods are known to those skilled in the art for over-expressing and isolating enzymatically-active polypeptides in suitable cells.
  • all expression systems available to the person skilled in the art can be used, for example vectors of the type pET or pGEX.
  • Purification can be carried out by chromatographic methods, for example the affinity chromatographic purification of a tagged recombinant protein using immobilized ligands, for example a nickel ion in the case of a histidine tag, of immobilized glutathione in the case of glutathione S-transferase fused to the target protein or immobilized maltose in the case of a tag comprising maltose-binding protein.
  • immobilized ligands for example a nickel ion in the case of a histidine tag
  • immobilized glutathione in the case of glutathione S-transferase fused to the target protein
  • maltose in the case of a tag comprising maltose-binding protein.
  • the purified enzymatically active polypeptides can be used either in soluble form or immobilized. Suitable methods are known to the person skilled in the art with which polypeptides can be immobilized covalently or noncovalently on organic or inorganic solid phases, for example by sulfhydryl coupling chemistry (eg kits from Pierce).
  • the cell used as the whole-cell catalyst or in the cell used as the expression system is a prokaryotic cell, preferably a bacterial cell. In a further preferred embodiment, it is a mammalian cell. In a further preferred embodiment, it is a lower eukaryotic cell, preferably a yeast cell.
  • Exemplary prokaryotic cells include Escherichia, especially Escherichia coli, and strains of the genus Pseudomonas and Corynebacterium.
  • Exemplary lower eukaryotic cells include the genera Saccharomyces, Candida, Pichia, Yarrowia, Schizosaccharomyces, especially the strains Candida tropicalis, Schizosaccharomyces pombe, Pichia pastoris, Yarrowia lipolytica and Saccharomyces cerivisiae.
  • the cell may contain one or more than one nucleic acid sequence coding for an enzyme used according to the invention on a plasmid or integrated into its genome.
  • it comprises a plasmid comprising a nucleic acid sequence coding for at least one enzyme, preferably more than one enzyme, most preferably for all enzymes from the group comprising NAD (P) + -dependent alcohol dehydrogenase, preferably with at least one zinc atom as cofactor, transaminase , Monooxygenase and alanine dehydrogenase.
  • the alcohol dehydrogenase is a zinc-containing NAD (P) + -dependent alcohol dehydrogenase, ie, the catalytically active enzyme comprises at least one zinc atom as a cofactor covalently attached to the polypeptide by a characteristic sequence motif comprising cysteine residues is bound.
  • the alcohol dehydrogenase is the alcohol dehydrogenase from Bacillus stearothermophilus (database code P42328) or a variant thereof.
  • teachings of the present invention may be made not only by using the exact amino acid or nucleic acid sequences of the biological macromolecules described herein, but also by using variants of such macromolecules obtained by deletion, addition or substitution of one or more amino acids or nucleic acids can.
  • the term "variant” means a nucleic acid sequence or amino acid sequence, in the following synonymous and interchangeable with the term "Homologous” as used herein employs another nucleic acid or amino acid sequence which, with respect to the corresponding original wild-type nucleic acid or amino acid sequence, uses homology, here synonymous with identity, of 70, 75, 80, 85, 90, 92, 94, 96, 98, 99% or more percent, preferably other than the catalytically active center forming amino acids or essential for the structure or folding amino acids are deleted or substituted or the latter are only conservatively substituted, for example, a glutamate instead of one Aspartate or a leucine rather than a valine
  • the art describes algorithms that can be used to calculate the extent of homology of two sequences, e.g., Arthur Lesk (2008), Introduction to bioinformatics, 3 rd edition
  • Another preferred embodiment of the present invention comprises the variant of an amino acid or nucleic acid sequence, in addition to the sequence homology mentioned above
  • a variant of a polypeptide enzymatically active as protease has the same or substantially the same proteolytic activity as the polypeptide enzyme, ie the ability to catalyze the hydrolysis of a peptide bond.
  • the term "substantially the same enzymatic activity” means activity with respect to the substrates of the wild-type polypeptide that is well above the background activity and / or is less than 3, more preferably 2, more preferably on the order of distinguishes the K M and / or k cat values which the wild-type polypeptide has with respect to the same substrates
  • the term "variant" of a nucleic acid or amino acid sequence comprises at least one active part or fragment of the nucleic acid sequence.
  • the term "active part" as used herein means an amino acid sequence or nucleic acid sequence which is less than full length of the amino acid sequence or less than full length of the amino acid sequence encoding the amino acid sequence or amino acid sequence the encoded amino acid sequence of lesser length than the wild-type amino acid sequence has substantially the same enzymatic activity as the wild-type polypeptide or a variant thereof, for example as alcohol dehydrogenase, monooxygenase or transaminase
  • the term "variant" of a nucleic acid comprises a nucleic acid whose complementary strand, preferably under stringent conditions, binds to the wild-type nucleic acid.
  • the stringency of the hybridization reaction is readily determinable by those skilled in the art and generally depends on the length of the probe, the temperatures at Washing and the salt concentration. In general, longer probes require higher temperatures for hybridization, whereas shorter probes manage at low temperatures. Whether hybridization takes place generally depends on the ability of the denatured DNA to anneal to complementary strands present in their environment, below the melting temperature. The stringency of hybridization reaction and corresponding conditions are more fully described in Ausubel et al. 1995 described.
  • the term "variant" of a nucleic acid as used herein includes any nucleic acid sequence encoding the same amino acid sequence as the original nucleic acid or a variant of that amino acid sequence in the context of degeneracy of the genetic code.
  • Alcohol dehydrogenases represent a highly respected and biotechnologically highly relevant class of enzymes in biochemistry in connection with brewery-technical fermentation processes, which comprises various groups of isoforms.
  • membrane-bound, flavin-dependent alcohol dehydrogenases of the Pseudomonas putida GP01 AlkJ type, which use flavocofactors instead of NAD + exist.
  • Another group includes iron-containing, oxygen-sensitive alcohol dehydrogenases found in bacteria and in inactive form in yeast.
  • Another group includes NAD + -dependent alcohol dehydrogenases, including zinc-containing alcohol dehydrogenases, in which the active site has a cysteine-coordinated zinc atom that fixes the alcohol substrate.
  • alcohol dehydrogenase refers to an enzyme which oxidizes an aldehyde or ketone to the corresponding primary or secondary alcohol, respectively.
  • the alcohol dehydrogenase in the process according to the invention is preferably an NAD + -dependent alcohol, ie an alcohol dehydrogenase, the NAD + as a cofactor for the oxidation of the alcohol or NADH for the reduction of the corresponding aldehyde or ketone used.
  • the alcohol dehydrogenase is the alcohol dehydrogenase A from Rhodococcus ruber (database code AJ491307.1) or a variant thereof Further examples comprising the alk Ralphonia eutropha (ACB78191 .1), Lactobacillus brevis (YP_795183.1), Lactobacillus kefiri (ACF95832.1), from horse liver, from Paracoccus pantotrophus (ACB78182.1) and Sphingobium yanoikuyae (EU427523.1,) and the respective variants thereof.
  • the term "NAD (P) + -dependent alcohol dehydrogenase” as used herein refers to an alcohol dehydrogenase that is N
  • a transaminase is used in step c).
  • the term "transaminase” as used herein means an enzyme which catalyzes the transfer of ⁇ -amino groups from a donor, preferably an amino acid, to an acceptor molecule, preferably an ⁇ -ketocarboxylic acid
  • the transaminase is selected from the group of transaminases and their variants which are characterized in that they correspond at the position of the amino acid sequence corresponding to Val224 from the transaminase of Chromobacterium violaceum ATCC 12472 (database code NP_901695), an amino acid selected from the group comprising isoleucine, valine, phenylalanine, methionine and leucine, and at the position of the amino acid sequence corresponding to Gly230 from the transaminase of Chromobacterium violaceum ATCC 12472 (database code NP_901695)
  • position corresponding to position X of the amino acid sequence from the transaminase of Chromobacterium violaceum ATCC 12472 means the corresponding position in an alignment of the molecule of interest as to position X of the amino acid sequence from the transaminase Chromobacterium violaceum ATCC 12472.
  • Numerous software packages and algorithms are known to those of skill in the art for making alignment of amino acid sequences Exemplary software packages Methods include the EMBL-supplied package ClustalW or are described in Arthur M. Lesk (2008), Introduction to Bioinformatics, 3rd edition, listed and described.
  • the enzymes used according to the invention are preferably recombinant enzymes.
  • the term "recombinant" as used herein means that the corresponding nucleic acid molecule is not in nature occurs and / or it was produced using genetic engineering methods.
  • a recombinant cell as used herein is understood to mean a cell having at least one recombinant nucleic acid or a recombinant polypeptide.
  • Those skilled in the art will be familiar with methods of making recombinant molecules or cells, such as those described in Sambrook et al., 1989.
  • the teaching of the invention can be carried out using isolated enzymes as well as using whole-cell catalysts.
  • the term "whole cell catalyst" as used herein means an intact, viable, and metabolically active cell that provides a desired enzymatic activity
  • the whole cell catalyst can be the substrate to be metabolized, in the case of the present invention, the alcohol or the
  • the resulting oxidation product may either be transported inside the cell where it is metabolized by cytosolic enzymes, or it may present the enzyme of interest on its surface where it is directly exposed to substrates in the medium. for example from DE 60216245.
  • isolated enzymes For a number of applications, the use of isolated enzymes is recommended.
  • isolated means that the enzyme is in a purer and / or more concentrated form than in its natural source
  • the enzyme is considered isolated if it is a polypeptide enzyme and more than 60, 70, 80, 90 or preferably 95% of the mass protein content of the corresponding preparation
  • numerous methods for measuring the mass of a protein in a solution for example the visual estimation based on the thickness of corresponding protein bands on SDS-polyacrylamide gels, NMR Spectroscopy or mass spectrometry based methods.
  • the enzymatically catalyzed reactions of the process according to the invention are typically carried out in a solvent or solvent mixture with a high water content, preferably in the presence of a suitable buffer system for the adjustment of a pH compatible with enzymatic activity.
  • a suitable buffer system for the adjustment of a pH compatible with enzymatic activity.
  • the additional presence of an organic co-solvent which can mediate the contact of the enzyme with the substrate is advantageous.
  • the one or more co-solvents is in a total proportion of the solvent mixture of or less than 95, 90, 85, 80, 75, 70, 65, 60, 55, 50, 45, 40, 35, 30, 25, 20, 15, 10 or 5 percent by volume.
  • the hydrophobicity of the co-solvent plays an important role. It can be represented by the logP, the decadic logarithm of the n-octanol-water partition coefficient.
  • a preferred cosolvent has a log P of greater than -1.38, more preferably from -1 to +2, even more preferably from -0.8 to 1.5, or -0.5 to 0.5 or -0.4 to 0 , 4 or -0.3 to 0.3 or -0.25 to -0.1.
  • K ow or P is a dimensionless distribution coefficient that indicates the ratio of the concentrations of a substance in a two-phase system of 1-octanol and water (see J. Sangster, Octanol-Water Partition Coefficients: Fundamentals and Physical Chemistry , Vol. 2 of Wiley Series in Solution Chemistry, John Wiley & Sons, Chichester, 1997). More specifically, K ow or P denotes the ratio of the concentration of the substance in the octanol-rich phase to its concentration in the water-rich phase.
  • the Kow value is a model measure of the relationship between lipophilicity (fat solubility) and hydrophilicity (water solubility) of a substance. It is expected that the distribution coefficient of a substance in the octanol-water system can also be used to estimate the distribution coefficients of this substance in other systems with an aqueous phase. Kow is greater than one if a substance is more soluble in fat-like solvents such as n-octanol, less than one if it is better soluble in water. Accordingly, Log P is positive for lipophilic and negative for hydrophilic substances. Since the kow can not be measured for all chemicals, there are various models for the prediction, eg.
  • log P is determined by the method of Advanced Chemistry Development Inc., Toronto by means of the program module ACD / LogP DB.
  • a preferred cosolvent has a log P of greater than -1.38, more preferably from -1 to +2, even more preferably from -0.5 to 0.5, -0.4 to 0.4 or 0 to 1.5.
  • the co-solvent is a dialkyl ether of the formula AlkO-Alk 2 having a logP greater than -1.38, more preferably from -1 to +2, even more preferably from 0 to 1.5. wherein the two alkyl substituents Alk- ⁇ and Alk 2 are each and independently selected from the group comprising methyl, ethyl, propyl, butyl, isopropyl and tert-butyl.
  • the cosolvent is methyl tertiary butyl ether (MTBE).
  • the cosolvent is dimethoxyethane (DME).
  • the cosolvent is a carboxylic acid or fatty acid, preferably a fatty acid having at least 6, more preferably at least 12 carbon atoms.
  • the fatty acid may be a saturated fatty acid, for example, lauric acid, myristic acid, palmitic acid, margaric acid, stearic acid, arachic acid or behenic acid, or an unsaturated, for example myristoleic, palmitoleic, petroselinic, oleic, elaidic, vaccenic, gadoleic, icosenoic or erucic acid.
  • mixtures of different fatty acids for example ball diuretic oil, which contains mainly unsaturated fatty acids.
  • fatty acids are appreciably soluble at room temperature, it may be necessary to take further measures, such as increasing the temperature or, preferably, adding another solvent to make them accessible to the aqueous phase.
  • a fatty acid or ester thereof preferably the methyl ester, most preferably methyl laurate, is used as such another solvent.
  • the enzymatic cascade according to the invention can proceed in the presence of an alanine dehydrogenase. It is a particular strength of the present invention that this embodiment allows a reduction equivalent neutral reaction, ie the reaction proceeds without supply or removal of electrons in the form of reduction equivalents, since the NADH produced by the alcohol dehydrogenase in the course of alcohol oxidation in the production of alanine Consumption of one inorganic nitrogen donor, preferably ammonia or an ammonia source is consumed.
  • alanine dehydrogenase refers to an enzyme that catalyzes the conversion of L-alanine to water, NAD + , pyruvate, ammonia and NADH, preferably alanine dehydrogenase an intracellular alanine dehydrogenase, more preferably a recombinant intracellular alanine dehydrogenase of a whole cell bacterial catalyst.
  • a whole-cell catalyst having all the required activities is used for the process according to the invention, ie NAD (P) + -dependent alcohol dehydrogenase, transaminase and optionally monooxygenase and / or alanine dehydrogenase.
  • P NAD
  • the use of such a whole-cell catalyst has the advantage that all activities are used in the form of a single agent and it is not necessary to process enzymes in biologically active form on an industrial scale.
  • Another object of the invention is to provide a system for the oxidation and amination of primary alcohols.
  • the object is achieved in a fourth aspect by a process comprising the steps of a) providing a primary alcohol of the formula
  • R 7 is selected from the group consisting of -OH, -SH, -NH 2 and -COOR 8 , x is at least 3, and R 8 is selected from the group consisting of H, alkyl and aryl includes, b) oxidation of the primary alcohol by contacting with an ND "dependent alcohol dehydrogenase, and c) contacting the oxidation product of step a) with a transaminase, wherein the NAD + alcohol dehydrogenase and / or the transaminase is a recombinant or isolated enzyme is.
  • step a) is carried out by hydroxylation of an alkane of the formula
  • the NAD * -dependent alcohol dehydrogenase is an NAD * -dependent alcohol dehydrogenase having at least one zinc atom as a cofactor.
  • the alcohol dehydrogenase is the alcohol dehydrogenase of Bacillus stearothermophilus (database code P42328) or a variant thereof.
  • the monooxygenase is selected from the group comprising AlkBGT of Pseudomonas putida, Cytochrome P450 of Candida tropicalis or Cicer arietinum.
  • the transaminase is selected from the group of transaminases and their variants, which are characterized in that they are at the position of the amino acid sequence, the Val224 from the transaminase of Chromobacterium violaceum ATCC 12472 (database code NP_901695), an amino acid selected from the group comprising isoleucine, valine, phenylalanine, methionine and leucine, and at the position of the amino acid sequence corresponding to Gly230 from the transaminase of Chromobacterium violaceum ATCC 12472 (database code NP_901695), an amino acid other than threonine and preferably an amino acid from the group comprising serine, cysteine, glycine and alanine.
  • step b) and / or step c) is carried out in the presence of an isolated or recombinant alanine dehydrogenase and an inorganic nitrogen source.
  • At least one enzyme selected from the group consisting of NAD * -dependent alcohol dehydrogenase, transaminase, monooxygenase and alanine dehydrogenase is recombinant and provided in the form of a whole-cell catalyst containing the corresponding Having enzyme.
  • all enzymes are provided in the form of one or more than one whole cell catalyst, preferably a whole cell catalyst having all the required enzymes.
  • an organic cosolvent is present which has a log P of more than -1.38, preferably -0.5 to 1.2, more preferably -0.4 to 0.4.
  • the cosolvent is selected from the group comprising unsaturated fatty acids, preferably oleic acid.
  • the cosolvent is a compound of the formula R 9 is -O- (CH 2 ) X -O-R 10 wherein each of R 9 and R 10 is independently selected from the group comprising methyl, ethyl, propyl and butyl and x is 1 to 4, wherein more preferably R 8 and R 10 are each methyl and x is 2.
  • the object is achieved in a fifth aspect by a whole-cell catalyst comprising an NAD * -dependent alcohol dehydrogenase, preferably with at least one zinc atom as cofactor, a transaminase, optionally a monooxygenase and optionally an alanine dehydrogenase, wherein the enzymes are recombinant enzymes.
  • the object in a sixth aspect is achieved by the use of the whole-cell catalyst according to the second aspect of the present invention for the oxidation and amination of a primary alcohol of the formula HO - (CH 2 ) X - R 7 , where R 7 is selected from the group -OH, -SH, -NH 2 and -COOR 8 , x is at least 3 and R 8 is selected from the group comprising H, alkyl and aryl.
  • the use further comprises the presence of an organic cosolvent having a log P of greater than -1.38, preferably -0.5 to 1.2, more preferably 0.4 to 0.4.
  • the co-solvent is selected from the group comprising unsaturated fatty acids, and is preferably oleic acid.
  • the inventors of the present invention have surprisingly found that there is a group of alcohol dehydrogenases that can be used to effect the oxidation of primary alcohols to produce minor amounts of by-products.
  • the inventors have further surprisingly found that a cascade of enzymatic activities exists, can be aminated with the alcohols without significant formation of by-products using biocatalysts, with no reduction equivalents must be added or removed.
  • the inventors have also surprisingly found a process by which polyamides can surprisingly be prepared using a whole-cell catalyst and starting from renewable raw materials.
  • the inventors of the present invention have further surprisingly found that the amination of primary alcohols after prior oxidation can be carried out particularly advantageously with a group of transaminases characterized by particular sequence properties.
  • the process according to the invention can be applied to a large number of industrially relevant alcohols.
  • this is a ⁇ -hydroxy carboxylic acid or an ester, preferably methyl ester, thereof, which is or are oxidized to an ⁇ -aminocarboxylic acid and aminated.
  • it is a diol which is oxidized to a diamine and aminated.
  • the primary alcohol is a hydroxyalkylamine.
  • the length of the carbon chain is variable and x is at least 3.
  • Exemplary compounds include ⁇ -hydroxy lauric acid, ⁇ -hydroxy lauric acid methyl ester, and alkane diols, especially 1,8-octane diol and 1, 10-decane diol.
  • R 1 is selected from the group comprising -OH and -COOR 2
  • x is at least 11
  • R 2 is selected from the group comprising H, methyl, ethyl and propyl.
  • the primary alcohol is an ⁇ -hydroxy fatty acid methyl ester.
  • NAD * -dependent alcohol dehydrogenases are used for the oxidation of the primary alcohol in step b) of the process.
  • these may be cells comprising enzymatically active polypeptides or their lysates or preparations of the polypeptides in all purification stages, from the crude lysate to the pure polypeptide.
  • a person skilled in the art knows numerous methods with which enzymatically active polypeptides are overexpressed and purified in suitable cells or can be isolated.
  • all expression systems available to the person skilled in the art can be used.
  • Purification can be carried out by chromatographic methods, for example affinity chromatographic purification of a tagged recombinant protein using an immobilized ligand, for example a nickel ion in the case of a histidine tag, of immobilized glutathione in the case of a glutathione-S-transferase fused to the target protein or immobilized maltose in the case of a tag comprising maltose binding protein.
  • an immobilized ligand for example a nickel ion in the case of a histidine tag
  • immobilized glutathione in the case of a glutathione-S-transferase fused to the target protein
  • maltose in the case of a tag comprising maltose binding protein.
  • the purified enzymatically active polypeptides can be used either in soluble form or immobilized.
  • the person skilled in the art is familiar with suitable methods by which polypeptides can be immobilized covalently or noncovalently on organic or inorganic solid phases, for example by sulfhydryl coupling chemistry (for example kits from Pierce or Quiagen).
  • the cell used as the whole-cell catalyst or in the cell used as the expression system is a prokaryotic cell, preferably a bacterial cell. In a further preferred embodiment, it is a mammalian cell. In a further preferred embodiment, it is a lower eukaryotic cell, preferably a yeast cell.
  • Exemplary prokaryotic cells include Escherichia, especially Escherichia coli, and strains of the genus Pseudomonas and Corynebacterium.
  • Exemplary lower eukaryotic cells include the genera Saccharomyces, Candida, Pichia, Yarrowia, Schizosaccharomyces, especially the strains Candida tropicalis, Schizosaccharomyces pombe, Pichia pastoris, Yarrowia lipolytica and Saccharomyces cerivisiae.
  • the alcohol dehydrogenase is a zinc-containing NAD * -dependent alcohol dehydrogenase, ie, the catalytically active enzyme comprises at least one zinc atom as a cofactor, which is covalently bound to the polypeptide by a characteristic sequence motif comprising cysteine residues.
  • the alcohol dehydrogenase is the alcohol dehydrogenase from Bacillus stearothermophilus (database code P42328) or a variant thereof.
  • the teachings of the present invention may be made not only by using the exact amino acid or nucleic acid sequences of the biological macromolecules described herein, but also by using variants of such macromolecules obtained by deletion, addition or substitution of one or more amino acids or nucleic acids can.
  • the term "variant" of a nucleic acid sequence or amino acid sequence hereinafter synonymous and interchangeable with the term “homologue” as used herein, means another nucleic acid or amino acid sequence that is unique with respect to the corresponding original wild-type nucleic acid sequence.
  • homology here used as identity, of 70, 75, 80, 85, 90, 92, 94, 96, 98, 99% or more percent, preferably other than the catalytically active center forming amino acids or for the structure or folding essential amino acids are deleted or substituted or the latter are only conservatively substituted, for example, a glutamate instead of an aspartate or a leucine instead of a valine.
  • the prior art describes algorithms that can be used to calculate the extent of homology of two sequences, e.g. B. Arthur Lesk (2008), Introduction to bioinformatics, 3 rd edition.
  • the variant of an amino acid or nucleic acid sequence preferably in addition to the sequence homology mentioned above, has essentially the same enzymatic activity of the wild-type molecule or the original molecule.
  • a variant of a polypeptide enzymatically active as protease has the same or substantially the same proteolytic activity as the polypeptide enzyme, ie the ability to catalyze the hydrolysis of a peptide bond.
  • the term "substantially the same enzymatic activity” means activity with respect to the substrates of the wild-type polypeptide that is well above the background activity and / or is less than 3, more preferably 2, more preferably on the order of distinguishes the K M and / or k cat values which the wild-type polypeptide has with respect to the same substrates
  • the term "variant" of a nucleic acid or amino acid sequence comprises at least one active part or fragment of the nucleic acid sequence. or amino acid sequence.
  • the term "active part" as used herein means an amino acid sequence or nucleic acid sequence which is less than full length of the amino acid sequence or less than full length of the amino acid sequence encoding the amino acid sequence or amino acid sequence the encoded amino acid sequence of lesser length than the wild-type amino acid sequence has substantially the same enzymatic activity as the wild-type polypeptide or a variant thereof, for example as alcohol dehydrogenase, monooxygenase or transaminase.
  • the term "variant" of a nucleic acid comprises a nucleic acid whose complementary strand binds to the wild-type nucleic acid, preferably under stringent conditions
  • the stringency of the hybridization reaction is readily determinable by a person skilled in the art and generally depends on the length of the probe In general, longer probes require higher temperatures for hybridization, whereas shorter probes can cope with low temperatures. Whether hybridization takes place generally depends on the ability of denatured DNA to anneal to complementary strands The stringency of the hybridization reaction and corresponding conditions are described in more detail in Ausübet et al., 1995.
  • the term "variant" of a nucleic acid wi e, any nucleic acid sequence coding for the same amino acid sequence as the original nucleic acid or a variant of this amino acid sequence in the context of the degeneracy of the genetic code.
  • Alcohol dehydrogenases represent a highly respected and biotechnologically highly relevant class of enzymes in biochemistry in connection with brewery-technical fermentation processes, which comprises various groups of isoforms.
  • membrane-bound, flavin-dependent alcohol dehydrogenases of the Pseudomonas putida GP01 AlkJ type, which use flavocofactors instead of NAD * exist.
  • Another group includes iron-containing, oxygen-sensitive alcohol dehydrogenases found in bacteria and in inactive form in yeast.
  • Another group includes NAD + -dependent alcohol dehydrogenases, including zinc-containing alcohol dehydrogenases, in which the active site has a cysteine-coordinated zinc atom that fixes the alcohol substrate.
  • alcohol dehydrogenase refers to an enzyme which oxidizes an aldehyde or ketone to the corresponding primary or secondary alcohol, respectively.
  • the alcohol dehydrogenase in the process according to the invention is preferably an NAD * -dependent alcohol dehydrogenase, ie an alcohol dehydrogenase, which uses NAD * as a cofactor for the oxidation of the alcohol or NADH for the reduction of the corresponding aldehyde or ketone.
  • the alcohol dehydrogenase is an NAD * -dependent, zinc-containing alcohol dehydrogenase.
  • a transaminase is used in step c).
  • the term "transaminase” as used herein means an enzyme which catalyzes the transfer of ⁇ -amino groups from a donor, preferably an amino acid, to an acceptor molecule, preferably an ⁇ -ketocarboxylic acid
  • the transaminase is selected from the group of transaminases and their variants which are characterized in that they correspond at the position of the amino acid sequence corresponding to Val224 from the transaminase of Chromobacterium violaceum ATCC 12472 (database code NP_901695), an amino acid selected from the group comprising isoleucine, valine, phenylalanine, methionine and leucine, and at the position of the amino acid sequence corresponding to Gly230 from the transaminase of Chromobacterium violaceum ATCC 12472 (database code NP_901695)
  • position corresponding to position X of the amino acid sequence from the transaminase of Chromobacterium violaceum ATCC 12472 means the corresponding position in an alignment of the molecule of interest as to position X of the amino acid sequence from the transaminase Chromobacterium violaceum ATCC 12472.
  • Exemplary Software Packages Methods include the EMBL-supplied package ClustalW (Larkin et al., 2007, Goujon et al ) or are listed and described in Arthur M. Lesk (2008), Introduction to Bioinformatics, 3rd edition.
  • the enzymes used according to the invention are preferably recombinant enzymes.
  • the term "recombinant" as used herein means that the corresponding nucleic acid molecule is not in nature occurs and / or it was produced using genetic engineering methods.
  • a recombinant cell as used herein is understood to mean a cell having at least one recombinant nucleic acid or a recombinant polypeptide.
  • Those skilled in the art will be familiar with methods of making recombinant molecules or cells, such as those described in Sambrook et al., 1989.
  • the teaching of the invention can be carried out using isolated enzymes as well as using whole-cell catalysts.
  • the term "whole cell catalyst" as used herein means an intact, viable, and metabolically active cell that provides a desired enzymatic activity
  • the whole cell catalyst can be the substrate to be metabolized, in the case of the present invention, the alcohol or the
  • the resulting oxidation product may either be transported into the cell interior where it is metabolized by cytosolic enzymes, or it may present the enzyme of interest on its surface where it is directly exposed to substrates in the medium , for example from DE 60216245.
  • isolated enzymes For a number of applications, the use of isolated enzymes is recommended.
  • isolated means that the enzyme is in a purer and / or more concentrated form than in its natural source
  • the enzyme is considered isolated if it is a polypeptide enzyme and more than 60, 70, 80, 90 or preferably 95% of the mass protein content of the corresponding preparation
  • numerous methods for measuring the mass of a protein in a solution for example the visual estimation based on the thickness of corresponding protein bands on SDS-polyacrylamide gels, NMR Spectroscopy or mass spectrometry based methods.
  • the enzymatically catalyzed reactions of the process according to the invention are typically carried out in a solvent or solvent mixture with a high water content, preferably in the presence of a suitable buffer system for the adjustment of a pH compatible with enzymatic activity.
  • a suitable buffer system for the adjustment of a pH compatible with enzymatic activity.
  • the additional presence of an organic co-solvent which can mediate the contact of the enzyme with the substrate is advantageous.
  • the one or more co-solvents is in a total proportion of the solvent mixture of or less than 95, 90, 85, 80, 75, 70, 65, 60, 55, 50, 45, 40, 35, 30, 25, 20, 15, 10 or 5 percent by volume.
  • the hydrophobicity of the co-solvent plays an important role. It can be represented by the logP, the decadic logarithm of the n-octanol-water partition coefficient.
  • a preferred cosolvent has a log P of greater than -1.38, more preferably from -1 to +2, even more preferably from -0.5 to 0.5 or -0.4 to 0.4 or 0 to 1.5.
  • K ° w or P is a dimensionless distribution coefficient that indicates the ratio of the concentrations of a substance in a two-phase system of 1-octanol and water (see J. Sangster, Octanol-Water Partition Coefficients: Fundamentals and Physical Chemistry, Vol. 2 of Wiley Series in Solution Chemistry, John Wiley & Sons, Chichester, 1997). More specifically, K ° w or P denotes the ratio of the concentration of the substance in the octanol-rich phase to its concentration in the water-rich phase.
  • the K ° w value is a model measure of the relationship between lipophilicity (fat solubility) and hydrophilicity (water solubility) of a substance. It is expected that the distribution coefficient of a substance in the octanol-water system can also be used to estimate the distribution coefficients of this substance in other systems with an aqueous phase. K ° w is greater than one if a substance is more soluble in fat-like solvents such as n-octanol, less than one if it is better soluble in water. Accordingly, Log P is positive for lipophilic and negative for hydrophilic substances. Since the K ° w can not be measured for all chemicals, there are various models for the prediction, eg.
  • log P is determined by the method of Advanced Chemistry Development Inc., Toronto by means of the program module ACD / LogP DB.
  • a preferred cosolvent has a log P of greater than -1.38, more preferably from -1 to +2, even more preferably from -0, 75 to 1.5 or -0.5 to 0.5 or -0.4 to 0 , 4 or -0.3 to -0, 1.
  • the co-solvent is a dialkyl ether of the formula AlKrO-Alk 2 having a logP greater than -1.38, more preferably from -1 to +2, more preferably includes from 0 to 1.5, wherein the two alkyl substituents are each independently selected and Alk 1 and Alk 2 from the group comprising methyl, ethyl, propyl, butyl, isopropyl and tert-butyl.
  • the cosolvent is methyl tertiary butyl ether (MTBE). In the most preferred embodiment, the cosolvent is dimethoxyethane (DME). In a further preferred embodiment, the cosolvent is a compound of the formula R 10 -O- (CH 2 ) X -O-R 11 wherein R 10 and R 11 are each and independently selected from the group consisting of methyl , Ethyl, propyl and butyl and x is 1 to 4, preferably R 10 and R 11 are each methyl and x is 2.
  • the cosolvent is a carboxylic acid or fatty acid, preferably a fatty acid having at least 6, more preferably at least 12 carbon atoms.
  • the fatty acid may be a saturated fatty acid, for example, lauric acid, myristic acid, palmitic acid, margaric acid, stearic acid, arachic acid or behenic acid, or an unsaturated, for example myristoleic, palmitoleic, petroselinic, oleic, elaidic, vaccenic, gadoleic, icosenoic or erucic acid.
  • mixtures of different fatty acids for example ball diuretic oil, which contains mainly unsaturated fatty acids.
  • fatty acids are appreciably soluble at room temperature, it may be necessary to take further measures, such as increasing the temperature or, preferably, adding another solvent to make them accessible to the aqueous phase.
  • a fatty acid or ester thereof preferably the methyl ester, most preferably methyl laurate, is used as such another solvent.
  • the enzymatic cascade according to the invention can proceed in the presence of an alanine dehydrogenase. It is a particular strength of the present invention that this embodiment allows a reduction equivalent neutral reaction procedure, ie the reaction proceeds without supply or removal of electrons in the form of reduction equivalents, since the NADH produced by the alcohol dehydrogenase in the course of alcohol oxidation in the production of alanine with consumption of an inorganic nitrogen donor, preferably ammonia or an ammonia source , is consumed.
  • an inorganic nitrogen donor preferably ammonia or an ammonia source
  • alanine dehydrogenase refers to an enzyme that catalyzes the conversion of L-alanine to water, NAD + , pyruvate, ammonia and NADH, preferably alanine dehydrogenase an intracellular alanine dehydrogenase, more preferably a recombinant intracellular alanine dehydrogenase of a bacterial whole cell talysa gate.
  • the process of the present invention employs a whole cell catalyst having all the required activities, i. NAD * -dependent alcohol dehydrogenase, transaminase and possibly monooxygenase and / or alanine dehydrogenase.
  • a whole-cell catalyst having all the required activities, i. NAD * -dependent alcohol dehydrogenase, transaminase and possibly monooxygenase and / or alanine dehydrogenase.
  • the use of such a whole-cell catalyst has the advantage that all activities are used in the form of a single agent and it is not necessary to process enzymes in biologically active form on an industrial scale.
  • FIG. 1 shows an exemplary alignment comprising various transaminases, in particular those of Chromobacterium violaceum ATCC 12472 (database code NP_901695, "TACV_co") corresponding to the positions Val224 and Gly230 of the latter transaminase Amino acid residues are underlined in all sequences. The alignment was made using ClustalW.
  • FIG. 2 shows the FMOC / HPLC analysis of the conversion of isosorbitol and ammonium salt catalysed by the three enzymes RasADH, pCR6 (L417M) and AlaDH (D196A / L197R) after 96 h. Shown are (a) the standards (1 mM each of the amino alcohols I, II, II and IV of FIG. 3 + 1 mM each of the diamines DAI, DAS and DAM), (b) those represented by RasADH, pCR6 (L417M) and AlaDH (D196A / L197R) catalyzed reaction after 96 h, (c) the control reaction as in (b) but without RasADH after 96 h.
  • Fig. 3 shows the chemical formulas of the starting substrate isosorbitol (1, 4: 3,6-dianhydro-D-sorbitol (ol)), the stereoisomers of the aminoalcohol (I to IV) and the stereoisomeric forms of the final diamine product (DAI: 2 , 5-diamino-1,4: 3,6-dianhydro-2,5-dideoxy-L-ldit (ol), DAS: 2,5-diamino-1,4: 3,6-dianhydro-2,5- Dideoxy-D-sorbitol (ol) and DAM: 2,5-diamino-1,4: 3,6-dianhydro-2,5-dideoxy-D-mannitol (ol).
  • DAI 2- , 5-diamino-1,4: 3,6-dianhydro-2,5-dideoxy-L-ldit (ol)
  • DAS 2,5-diamino-1,4: 3,6-dianhydro-2,5
  • Figure 4 shows the yields of mono- and diamine from FMOC / HPLC analysis of RasADH, pCR6 (L417M) and AlaDH (D196A / L197R) catalyzed reaction of isosorbitol and ammonium acetate at different ammonium concentrations.
  • Reaction conditions 300 mM isosorbitol, 2 mM NADP +, 100-300 mM NH 4 OAc, 5 mM L-alanine, 0.3 mM PLP, 132 ⁇ RasADH, 40 ⁇ PCR6 (L417M), 24 ⁇ AlaDH (D196A / L197R) in 25 mM Hepes / NaOH, pH 8.3; Incubation at 30 ° C. 5 shows a chromatogram with the analysis of a sample obtained according to Example 3 in the oxidation and amination of the secondary alcohol tripropylene glycol according to the invention. The arrow marks the peak representing oxidized and aminated tripropylene glycol.
  • Example 1 Amination of various substrates using an NAD + -dependent alcohol dehydrogenase in comparison to the alcohol dehydrogenase AlkJ using the method according to the invention
  • the substrates used were cyclohexanol (1), (S) -octan-2-ol (2) and (S) -4-phenylbutan-2-ol (3).
  • Bacillus subtilis L-alanine dehydrogenase was expressed in E. coli. First, an overnight culture was prepared which was subsequently used to inoculate the major culture (LB ampicillin medium). The cells were incubated for 24 hours at 30 ° C and 120 rpm on a shaker. IPTG (0.5 mM, isopropyl ⁇ -D-1-thiogalactopyranoside, Sigma) was then added for induction under sterile conditions and the cultures were shaken for a further 24 hours at 20 ° C.
  • IPTG 0.5 mM, isopropyl ⁇ -D-1-thiogalactopyranoside, Sigma
  • the cells were centrifuged off (8000 rpm, 4 ° C. for 20 minutes), washed and the supernatant discarded. The cells were then disrupted using ultrasound (1 s pulse, 4 s rest, 10 min time, 40% amplitude), the mixture was spun down (20 min, 18000 rpm, 4 ° C.) and the enzyme was purified using a His-prep column purified.
  • Alcohol dehydrogenase from Bacillus stearothermophilus (ADH-hT; P42328.1))
  • NAD + -dependent alcohol dehydrogenase from Bacillus stearothermophilus (iorentino G, Cannio R, Rossi M, Bartolucci S: Decreasing the stability and changing the substrate specificity of the Bacillus stearothermophilus alcohol dehydrogenase by single amino acid replacements., Protein Eng 1998, 11 : 925-930), an overnight culture was first prepared (10 ml LB / ampicillin medium, ampicillin 100 ⁇ g ml, 30 ° C, 120 rpm), which was then used to inoculate culture vessels, again at 37 ° C for about 12 hours and shaken 120 rpm.
  • the cells were centrifuged off (8000 rpm, 20 minutes, 4 ° C), washed, the supernatant discarded and the pellet lyophilized. Finally, the cells were disrupted using ultrasound (1 s pulse, 4 s pause, 10 min time, 40% amplitude), the mixture was spun down (20 min, 18000 rpm, 4 ° C) and used as a kruds extract. The protein concentration was estimated by SDS-PAGE.
  • AlkJ alcohol dehydrogenase (from Pseudomonas oleovirans Gpo1):
  • the enzyme was prepared under the same conditions as the Bacillus stearothermophilus alcohol dehydrogenase, except that the plasmid pTZE03_AlkJ (SEQ ID NO 20) and kanamycin were used as the antibiotic (50 ⁇ g / ml).
  • the protein concentration was also estimated by SDS-PAGE.
  • the substrate is dissolved in the appropriate amount of cosolvent (DME) and dissolved in 300 ⁇ of water.
  • L-alanine was added.
  • ammonium chloride was added.
  • NAD + and PLP dissolved in 25 ⁇ of water were added thereto.
  • the pH was adjusted by adding 7.5 ⁇ M of a 6 M NaOH solution.
  • Transaminase and alanine dehydrogenase were added. The reaction was started by addition of alcohol dehydrogenase. After 22 hours, the reaction was stopped by addition of the derivatization reagents listed below.
  • the reaction was by addition of 200 ⁇ alcohol dehydrogenase (NAD + -dependent) or AlkJ) and transaminase started.
  • the samples were shaken at 25 ° C and 300 rpm for 24 hours.
  • the samples were worked up as described above and analyzed by GC-MS.
  • Example 2 Synthesis of mono- and diamines from isosorbitol and ammonium salts by coupled enzymatic reaction of an alcohol dehydrogenase, an aminotransferase and an alanine dehydrogenase
  • the following example shows the embodiment of the teaching according to the invention using a further, structurally different substrate and an NADP + -dependent alcohol dehydrogenase.
  • the structural gene of the alcohol dehydrogenase from Ralstonia sp. (SEQ ID NO: 25) was amplified by PCR using the oligodeoxynucleotides ADHfw (SEQ ID NO: 35) and ADHrv (SEQ ID NO: 36) from the plasmid pEam-RasADH (Lavandera et al., (2008) J. Org.
  • the gene of aminotransferase from Paracoccus denitrificans (SEQ ID NO: 37) was amplified by PCR using the oligodeoxynucleotides pCR6fw (SEQ ID NO: 38) and pCR6rv (SEQ ID NO: 39) from the plasmid pET21 a (+) - pCR6, with the restriction enzyme Hind ⁇ 'at the 3' end and finally ligated with the expression vector pASK-IBA35 (+), which was cut with the restriction enzymes Ehe ⁇ and Hind ⁇ .
  • the plasmid coding for the enzyme variant L417M of the aminotransferase was isolated by site-directed mutagenesis of the plasmid pASK-IBA35 (+) - pCR6 according to the QuikChange method (Agilent, Waldbronn) using the oligodeoxynucleotides pCR6_L417Mfw (SEQ ID NO: 20) and pCR6_L417Mrv (SEQ ID NO: 41).
  • the resulting expression plasmid pASK-IBA35 (+) - pCR6 (L417M) was verified by DNA sequencing.
  • the culture was harvested and the Cells in 40 mM Hepes / NaOH pH 7.5, 0.5 M NaCl and mechanically digested in a French-Press homogenizer.
  • the clear supernatant was applied to a Zn 2+ -charged Chelating Sepharose TM Fast Flow column and the His 6 -tag fused enzymes to a linear imidazole / HCl concentration gradient from 0 to 500 mM in 40 mM Hepes / NaOH pH 7, 5, 0.5 M NaCl eluted.
  • the elution fractions were concentrated by ultrafiltration and purified by gel filtration on Superdex200 in the presence of 25 mM Hepes / NaOH pH 8.3.
  • the three purified enzymes were used directly for the amination of isosorbitol (1, 4: 3,6-dianhydro-D-sorbitol (ol)) with recycling of the redox factors NADP + and L-alanine.
  • the enzyme test was composed as follows:
  • Example 1 For work-up, the samples were heated in a microwave at 600 W for about 15 seconds and then centrifuged off. Detection was carried out as described in Example 1.
  • Tripropylene glycol as a secondary alcohol was also used to detect the formation of oxidized and aminated product. This demonstrates the feasibility of the teaching of the invention over a broad spectrum of substrates.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un procédé comprenant les étapes suivantes : a) la préparation d'un alcool secondaire ; b) l'oxydation de l'alcool secondaire par mise en contact avec une alcool déshydrogénase dépendante de NAD(P)+ ; et c) la mise en contact du produit d'oxydation issu de l'étape a) avec une transaminase, l'alcool déshydrogénase dépendante de NAD(P)+ et/ou la transaminase étant une enzyme de recombinaison ou isolée. La présente invention concerne également un catalyseur à cellules entières pour la mise en œuvre du procédé, et l'utilisation d'un tel catalyseur à cellules entières pour l'oxydation d'un alcool secondaire.
EP12740366.5A 2011-08-05 2012-07-27 Oxydation et amination d'alcools secondaires Withdrawn EP2739744A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12740366.5A EP2739744A1 (fr) 2011-08-05 2012-07-27 Oxydation et amination d'alcools secondaires

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11006458 2011-08-05
EP12157917 2012-03-02
EP12740366.5A EP2739744A1 (fr) 2011-08-05 2012-07-27 Oxydation et amination d'alcools secondaires
PCT/EP2012/064805 WO2013020839A1 (fr) 2011-08-05 2012-07-27 Oxydation et amination d'alcools secondaires

Publications (1)

Publication Number Publication Date
EP2739744A1 true EP2739744A1 (fr) 2014-06-11

Family

ID=46582707

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12740366.5A Withdrawn EP2739744A1 (fr) 2011-08-05 2012-07-27 Oxydation et amination d'alcools secondaires

Country Status (8)

Country Link
US (1) US20140308717A1 (fr)
EP (1) EP2739744A1 (fr)
JP (1) JP2014524245A (fr)
CN (2) CN107034247A (fr)
BR (1) BR112014002732A8 (fr)
CA (1) CA2844090A1 (fr)
RU (1) RU2014108194A (fr)
WO (1) WO2013020839A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010043470A1 (de) 2010-11-05 2012-05-10 Evonik Degussa Gmbh Zusammensetzung aus Polyamiden mit niedriger Konzentration an Carbonsäureamidgruppen und elektrisch leitfähigem Kohlenstoff
DE102010043473A1 (de) 2010-11-05 2012-05-10 Evonik Degussa Gmbh Carbon Nanotubes enthaltende Polyamid 12-Zusammensetzung
DE102011075162A1 (de) 2010-12-08 2012-06-14 Evonik Degussa Gmbh Verfahren zur homogen-katalysierte, hochselektiven direkten Aminierung von primären Alkoholen mit Ammoniak zu primären Aminen bei hohem Volumenverhältnis von Flüssig- zu Gasphase und/oder hohen Drücken
UA112980C2 (uk) 2011-02-16 2016-11-25 Евонік Дегусса Гмбх Рідкі катіоніти
RU2013142804A (ru) 2011-02-21 2015-03-27 Эвоник Дегусса Гмбх Способ прямого аминирования спиртов аммиаком до первичных аминов с помощью каталитической системы на основе ксантфоса
US9580732B2 (en) 2011-07-20 2017-02-28 Evonik Degussa Gmbh Oxidation and amination of primary alcohols
DE102011084521A1 (de) 2011-10-14 2013-04-18 Evonik Industries Ag Verwendung einer Mehrschichtfolie mit Polyamid- und Polypropylenschichten für die Herstellung photovoltaischer Module
EP2602328A1 (fr) * 2011-12-05 2013-06-12 Evonik Industries AG Procédé d'oxydation d'alcanes en utilisant d'une alcane 1-mono-oxygénase AlkB
EP2607490A1 (fr) 2011-12-22 2013-06-26 Evonik Industries AG Procédé de séparation améliorée d'une solution organique hydrophobe et d'un milieu de culture aqueux
EP2639308A1 (fr) 2012-03-12 2013-09-18 Evonik Industries AG Omega-oxydation et -amination enzymatique d'acides gras
DE102012204181A1 (de) 2012-03-16 2013-09-19 Evonik Degussa Gmbh Elektrisch leitfähigen Kohlenstoff enthaltende Polyamidzusammensetzung
EP2647696A1 (fr) 2012-04-02 2013-10-09 Evonik Degussa GmbH Procédé de fabrication aérobie d'alanine ou d'une liaison établie sous consommation d'alanine
EP2653538A1 (fr) * 2012-04-20 2013-10-23 Evonik Industries AG Alanine-déshydrogénase NADP-dépendante
DE102012207921A1 (de) 2012-05-11 2013-11-14 Evonik Industries Ag Mehrstufiges Syntheseverfahren mit Synthesegas
EP2700448A1 (fr) 2012-08-21 2014-02-26 Evonik Industries AG Acides gras ramifiés comme échangeurs de cations liquides
ES2531144T3 (es) 2012-09-07 2015-03-11 Evonik Industries Ag Composiciones curables a base de resinas epoxídicas sin alcohol bencílico
EP2730655A1 (fr) 2012-11-12 2014-05-14 Evonik Industries AG Procédé de conversion d'un ester d'acide carboxylique en utilisant des cellules déficientes en BioH
EP2746400A1 (fr) 2012-12-21 2014-06-25 Evonik Industries AG Fabrication d'amines et de diamines à partir d'acide carbonique ou d'acide de dicarbone ou un mono-ester composé de ceux-ci
EP2746397A1 (fr) 2012-12-21 2014-06-25 Evonik Industries AG Fabrication d'acides gras oméga-aminés
EP2759598A1 (fr) 2013-01-24 2014-07-30 Evonik Industries AG Procédé de fabrication d'alpha, oméga-alcane-diol
EP2944697A1 (fr) 2014-05-13 2015-11-18 Evonik Degussa GmbH Procédé de production de nylon
EP2963121A1 (fr) * 2014-07-03 2016-01-06 Basf Se Amination biocatalytique autonome redox d'alcools
ES2803208T3 (es) 2015-12-17 2021-01-25 Evonik Operations Gmbh Una célula acetogénica genéticamente modificada
WO2018019867A1 (fr) 2016-07-27 2018-02-01 Evonik Degussa Gmbh N-acétyl homosérine
WO2018157395A1 (fr) * 2017-03-03 2018-09-07 Rhodia Operations Procédé de préparation d'une amine par réaction d'amination directe
CN112094830B (zh) * 2017-11-15 2022-06-24 凯莱英生命科学技术(天津)有限公司 转氨酶突变体及其应用
JP7045448B2 (ja) * 2017-11-15 2022-03-31 アシムケム ライフ サイエンス （ティエンジン） カンパニー リミテッド トランスアミナーゼ突然変異体及びその使用
EP3733689B1 (fr) 2018-02-05 2022-10-26 Asymchem Life Science (Tianjin) Co., Ltd Mutant de transaminase et utilisation associée
CN110551771B (zh) * 2018-05-31 2022-05-17 中国科学院天津工业生物技术研究所 一种手性3-氨基-1-丁醇的合成方法
CN114672526B (zh) * 2022-04-20 2024-01-26 南京工业大学 一种利用氧化还原中和体系从醇胺合成卤化吲哚的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259151A1 (en) 2001-03-02 2004-12-23 Joachim Jose Functional surface display of polypeptides
DE102007042600A1 (de) * 2007-09-07 2009-03-12 Evonik Degussa Gmbh Verfahren zur Herstellung von enantiomerenangereichten Aminen
KR20100061571A (ko) * 2007-09-28 2010-06-07 코덱시스, 인코포레이티드 케토리덕타제 폴리펩티드 및 이의 용도
CN101939422B (zh) * 2007-11-16 2014-11-26 衣阿华大学研究基金会 喷雾干燥的微生物及制备和使用的方法
DE102007060705A1 (de) * 2007-12-17 2009-06-18 Evonik Degussa Gmbh ω-Aminocarbonsäuren oder ihre Lactame, herstellende, rekombinante Zellen
WO2010085731A2 (fr) * 2009-01-23 2010-07-29 Microbia, Inc. Production de 1,4-butanediol dans un microorganisme
DE102009000592A1 (de) * 2009-02-04 2010-08-05 Evonik Degussa Gmbh Verfahren zur Herstellung von Aminogruppen tragenden, multizyklischen Ringsystemen
IN2012DN02121A (fr) * 2009-09-11 2015-08-21 Dsm Ip Assets Bv

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EDEGGER K ET AL: "Biocatalytic oxidation of sec-alcohols via hydrogen transfer", JOURNAL OF MOLECULAR CATALYSIS A: CHEMICAL, ELSEVIER, AMSTERDAM, NL, vol. 251, no. 1-2, 17 May 2006 (2006-05-17), pages 66 - 70, XP028015270, ISSN: 1381-1169, [retrieved on 20060517], DOI: 10.1016/J.MOLCATA.2006.02.007 *
JOERG H SCHRITTWIESER ET AL: "Recent biocatalytic oxidationreduction cascades", CURRENT OPINION IN CHEMICAL BIOLOGY, vol. 15, no. 2, April 2011 (2011-04-01), pages 249 - 256, XP028187359, ISSN: 1367-5931, [retrieved on 20101111], DOI: 10.1016/J.CBPA.2010.11.010 *
See also references of WO2013020839A1 *

Also Published As

Publication number Publication date
WO2013020839A1 (fr) 2013-02-14
CA2844090A1 (fr) 2013-02-14
BR112014002732A8 (pt) 2017-06-20
BR112014002732A2 (pt) 2017-06-13
CN107034247A (zh) 2017-08-11
CN103827309A (zh) 2014-05-28
RU2014108194A (ru) 2015-09-10
US20140308717A1 (en) 2014-10-16
JP2014524245A (ja) 2014-09-22

Similar Documents

Publication Publication Date Title
EP2739744A1 (fr) Oxydation et amination d'alcools secondaires
EP2734631B1 (fr) Oxydation et amination d'alcools secondaires
EP2653538A1 (fr) Alanine-déshydrogénase NADP-dépendante
EP2834347B1 (fr) Procédé de fabrication aérobie d'alanine
EP2746399B1 (fr) Fabrication d'acides gras oméga-aminés
EP2788493B1 (fr) Utilisation d'une alcane 1-mono-oxygénase alkb pour l'oxydation du propane et du butane
DE102007060705A1 (de) ω-Aminocarbonsäuren oder ihre Lactame, herstellende, rekombinante Zellen
WO2013135650A1 (fr) Oméga-oxydation et -amination enzymatique d'acides gras
EP2935602B1 (fr) Fabrication d'amines et de diamines à partir d'acide carbonique ou d'acide de dicarbone ou un mono-ester composé de ceux-ci
EP2948555A1 (fr) Procédé de production d'alpha, oméga-alcane-diol
EP2888046B1 (fr) Acides gras ramifiés employés en tant qu'échangeurs de cations liquides
DE112016001706B4 (de) Verfahren zur Herstellung von verschiedenen Lactamen
WO2019002459A1 (fr) Enzymes et procédé pour la réduction stéréosélective de composés carbonyle, l'oxydation, ainsi que l'amination réductive stéréosélective – pour la préparation énantiosélective de composés alcool-amines
WO2014190956A1 (fr) Procédé de production de cathine
EP1959019A1 (fr) Procédé destiné à la réduction enzymatique de dérivés d'alcènes
WO2009037216A1 (fr) Procédé d'oxydation de groupes méthyle dans des hydrocarbures aliphatiques par utilisation d'un système enzymatique ayant l'activité d'une mono-oxygénase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140110

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20160927

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170408